Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Clinical Relevance of CDH1 and CDH13 DNA-Methylation in Serum of Cervical Cancer Patients

5 Jul 2012

Abstract excerpt

This study was designed to investigate the DNA-methylation status of E-cadherin (CDH1) and H-cadherin (CDH13) in serum samples of cervical cancer patients and control patients with no malignant diseases and to evaluate the clinical utility of these markers. DNA-methylation status of CDH1 and CDH13 was analyzed by means of MethyLight-technology in serum samples from 49 cervical cancer patients and 40 patients with...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cancer-related gene regulation
Share to Cervical Cancer and HPV Research
Share to Epigenetics and DNA Methylation

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 22942707
DOI: 10.3390/ijms13078353

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Clinical Relevance of CDH1 and CDH13 DNA-Methylation in Serum of Cervical Cancer PatientsPMID 22942707Read ↗

CDH1 and CDH13 methylation in serum is an independent prognostic marker in cervical cancer patientsSemantic proximity Read ↗

Methylation pattern of CDH1 promoter and its association with CDH1 gene expression in cytological cervical specimensSemantic proximity Read ↗

A Systematic Analysis of the Relationship of CDH13 Promoter Methylation and Breast Cancer Risk and Prognosis.Semantic proximity Read ↗

Clinical Significance of CDH13 Promoter Methylation in Serum Samples from Patients with Bladder Transitional Cell CarcinomaSemantic proximity Read ↗

DNA Methylation in Serum and Tumors of Cervical Cancer PatientsSemantic proximity Read ↗

Detection of aberrant methylation of HOXA9 and HIC1 through multiplex MethyLight assay in serum DNA for the early detection of epithelial ovarian cancerSemantic proximity Read ↗

Promoter hypermethylation of CDH13 is a common, early event in human esophageal adenocarcinogenesis and correlates with clinical risk factorsSemantic proximity Read ↗

Hypermethylation of E‐cadherin is an independent predictor of improved survival in head and neck squamous cell carcinomaSemantic proximity Read ↗

CADM1 , MAL and miR124-2 methylation analysis in cervical scrapes to detect cervical and endometrial cancerSemantic proximity Read ↗

Global methylation silencing of clustered <i>proto‐cadherin</i> genes in cervical cancer: serving as diagnostic markers comparable to HPVSemantic proximity Read ↗

Loss of Expression and Aberrant Methylation of the CDH1 (E-cadherin) Gene in Breast Cancer Patients from KashmirSemantic proximity Read ↗

Aberrant Methylation of CDH13 is a Potential Biomarker for Predicting the Recurrence and Progression of Non Muscle Invasive Bladder CancerSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.